Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries
have important clinical consequences and may lead to acute liver failure, chronic liver …

Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the
predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific …

Budd-Chiari syndrome (BCS) is a rare hepatic vascular disorder defined by the presence of
partial or complete impairment of hepatic venous drainage in the absence of right heart …

Background & Aims A broad range of hepatocellular nodules has been reported in hepatic
vascular disorders. It is not clear whether hepatocellular adenoma (HCA) in this context …

In Europe and North America, hepatocellular adenomas (HCA) occur, classically, in middle‐
aged woman taking oral contraceptives. Twenty percent of women, however, are not …

Background. To evaluate clinical characteristics and factors associated with survival among
liver transplantation (LT) recipients with Budd-Chiari syndrome (BCS), with or without …

Introduction: The incidence of hepatocellular carcinoma (HCC) in Budd-Chiari syndrome
(BCS) is unknown and there is no validated diagnostic work-up to define the liver nodules …

Hepatocellular adenomas (HCAs) are composed of four molecular subgroups: mutations
inactivating the HNF1A gene; the inflammatory phenotype with mutations of different genes …

Abstract Budd–Chiari syndrome (BCS)-associated hepatocellular carcinoma (HCC) is a rare
condition; however, HCC may occur during the follow-up of a chronic BCS, as well as for …

The Liver Imaging Reporting and Data System (LIRADS, LR) is a system for standardized
imaging and reporting of hepatocellular carcinoma (HCC) in the contexts of …